Tcrcure Biopharma Ltd.
Clinical trials sponsored by Tcrcure Biopharma Ltd., explained in plain language.
-
Experimental CAR-T therapy targets stubborn tumors in tiny trial
Disease control TerminatedThis early-phase trial tested a new type of immune cell therapy called ALPP CAR-T cells in 5 people with advanced solid tumors that had stopped responding to other treatments. The therapy was designed to target a protein called ALPP found on the surface of some tumor cells. The s…
Phase: EARLY_PHASE1 • Sponsor: TCRCure Biopharma Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Experimental cell therapy for cervical cancer stalls after just 5 patients
Disease control TerminatedThis early-phase trial tested a new treatment called TC-E202 for people with advanced cervical cancer that had stopped responding to standard treatments. TC-E202 uses a patient's own immune cells, which are genetically modified in a lab to better recognize and attack cancer cells…
Phase: PHASE1, PHASE2 • Sponsor: TCRCure Biopharma Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC